Sage Therapeutics Statistics
Total Valuation
SAGE has a market cap or net worth of $841.49 million. The enterprise value is $92.14 million.
| Market Cap | 841.49M |
| Enterprise Value | 92.14M |
Important Dates
The next confirmed earnings date is Thursday, April 25, 2024, before market open.
| Earnings Date | Apr 25, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SAGE has 60.11 million shares outstanding. The number of shares has increased by 0.89% in one year.
| Shares Outstanding | 60.11M |
| Shares Change (YoY) | +0.89% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 12.56% |
| Owned by Institutions (%) | 95.59% |
| Float | 47.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.73 |
| Forward PS | 23.80 |
| PB Ratio | 1.05 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.07 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.51, with a Debt / Equity ratio of 0.01.
| Current Ratio | 10.51 |
| Quick Ratio | 10.12 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -58.00% and return on invested capital (ROIC) is -72.06%.
| Return on Equity (ROE) | -58.00% |
| Return on Assets (ROA) | -52.40% |
| Return on Capital (ROIC) | -72.06% |
| Revenue Per Employee | $177,526 |
| Profits Per Employee | -$1.11M |
| Employee Count | 487 |
| Asset Turnover | 0.08 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -70.35% in the last 52 weeks. The beta is 0.85, so SAGE's price volatility has been lower than the market average.
| Beta (1Y) | 0.85 |
| 52-Week Price Change | -70.35% |
| 50-Day Moving Average | 19.12 |
| 200-Day Moving Average | 22.59 |
| Relative Strength Index (RSI) | 33.75 |
| Average Volume (30 Days) | 998,117 |
Short Selling Information
The latest short interest is 8.60 million, so 14.31% of the outstanding shares have been sold short.
| Short Interest | 8.60M |
| Short Previous Month | 8.40M |
| Short % of Shares Out | 14.31% |
| Short % of Float | 18.09% |
| Short Ratio (days to cover) | 10.28 |
Income Statement
In the last 12 months, SAGE had revenue of $86.46 million and -$541.49 million in losses. Loss per share was -$9.05.
| Revenue | 86.46M |
| Gross Profit | 84.30M |
| Operating Income | -579.85M |
| Pretax Income | -541.49M |
| Net Income | -541.49M |
| EBITDA | -540.10M |
| EBIT | -541.49M |
| Loss Per Share | -$9.05 |
Balance Sheet
The company has $754.52 million in cash and $5.17 million in debt, giving a net cash position of $749.35 million or $12.47 per share.
| Cash & Cash Equivalents | 754.52M |
| Total Debt | 5.17M |
| Net Cash | 749.35M |
| Net Cash Per Share | $12.47 |
| Equity / Book Value | 799.53M |
| Book Value Per Share | 13.30 |
| Working Capital | 786.60M |
Cash Flow
In the last 12 months, operating cash flow was -$540.59 million and capital expenditures -$553,000, giving a free cash flow of -$541.14 million.
| Operating Cash Flow | -540.59M |
| Capital Expenditures | -553,000 |
| Free Cash Flow | -541.14M |
| FCF Per Share | -$9.04 |
Margins
Gross margin is 97.50%, with operating and profit margins of -670.69% and -626.32%.
| Gross Margin | 97.50% |
| Operating Margin | -670.69% |
| Pretax Margin | -626.32% |
| Profit Margin | -626.32% |
| EBITDA Margin | -624.71% |
| EBIT Margin | -626.32% |
| FCF Margin | -625.92% |
Dividends & Yields
SAGE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.89% |
| Shareholder Yield | -0.89% |
| Earnings Yield | -64.35% |
| FCF Yield | -64.31% |
Analyst Forecast
The average price target for SAGE is $21.47, which is 53.36% higher than the current price. The consensus rating is "Hold".
| Price Target | $21.47 |
| Price Target Difference | 53.36% |
| Analyst Consensus | Hold |
| Analyst Count | 16 |
| Revenue Growth Forecast (5Y) | 52.39% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SAGE has an Altman Z-Score of 1.17 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.17 |
| Piotroski F-Score | 3 |